Detalhe da pesquisa
1.
Low FHL1 expression indicates a good prognosis and drug sensitivity in ovarian cancer.
Funct Integr Genomics
; 24(1): 25, 2024 Feb 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38324167
2.
PABPN1 functions as a predictive biomarker in colorectal carcinoma.
Mol Biol Rep
; 51(1): 40, 2023 Dec 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38158471
3.
Correction to: Low FHL1 expression indicates a good prognosis and drug sensitivity in ovarian cancer.
Funct Integr Genomics
; 24(3): 96, 2024 May 14.
Artigo
Inglês
| MEDLINE | ID: mdl-38740604
4.
Letter re: Ki-67 index after neoadjuvant endocrine therapy as a prognostic biomarker in patients with ER-positive/HER2-negative early breast cancer: A systematic review and meta-analysis.
Eur J Cancer
; : 114126, 2024 May 22.
Artigo
Inglês
| MEDLINE | ID: mdl-38797636
5.
Comment on "Prognostic and Clinical Significance of Human Leukocyte Antigen Class I Expression in Breast Cancer: A MetaAnalysis".
Mol Diagn Ther
; 28(2): 237-238, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38376655